Another Gold High? Here's the Move Wall Street Is Missing ...

Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

Johnson & Johnson
NYSE:JNJ
$195.32
Open 194.99 Prev Close 194.39
High 196.00 Low 193.45
Volume 1,134,731 Volume (Avg) 8,235
52 Week High 195.55 52 Week Low 137.37
Market Cap 470.6B PE Ratio 18.85

General

NameJohnson & Johnson
TickerJNJ
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees138,100

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Highlights

Analyst Target206.45
Market Cap470,571,500,000
PE Ratio18.85
PEG Ratio1.05
EBITDA31,921,999,872

Valuation

Trailing PE18.80
Forward PE16.86
Price/Sales (Trailing 12 Mt.)5.08
Price/Book (Most Recent Quarter)5.89

Technicals

Beta0.36
52 Week High195.55
52 Week Low137.37
50 Day Average5.30%
200 Day Average17.22%

Dividend

Johnson & Johnson pays out a dividend of $5.19 per share, with a dividend yield of 2.66%.

JNJ's next dividend payment will be made to shareholders on December 9, 2025.

They pay out 84.80% of their earnings out as a dividend.

Recent Dividends

Dec 9, 2025$1.30
Sep 9, 2025$1.30
Jun 10, 2025$1.30
Mar 4, 2025$1.24
Dec 10, 2024$1.24
Sep 10, 2024$1.24
Jun 4, 2024$1.24
Mar 5, 2024$1.19
Dec 5, 2023$1.19
Most Popular

A jar of local flavors can spark memories and add a personal touch to gift-giving

A gift doesn’t have to be big or pricy to feel thoughtful. Instead of the usual bottle of wine, give something that makes your recipient feel truly seen: a little that nods to their hometown, heritage or favorite trip from years ago.

China's Singles' Day online shopping bonanza's sales slow as shoppers opt for more affordable deals

BANGKOK (AP) — Sales during China's largest online shopping festival, Singles' Day, jumped almost 18% from a year earlier but the pace of growth slowed as bargain hunters opted for more affordable deals.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

California revokes 17,000 driver's licenses. But the state disputes it is over immigration concerns

California plans to revoke 17,000 commercial driver’s licenses given to immigrants after the Trump administration raised concerns about people in the country illegally receiving licenses to drive a semitruck or a bus. But Gov. Gavin Newsom said that isn't the reason.

A Low-Profile Memecoin Is Quietly Gaining Serious Momentum - Ad

While everyone's watching the big-name coins, a lesser-known memecoin is gathering speed. With unique utility, a growing user base, and strong chart signals, our research team believes this could be a breakout waiting to happen.

AMD, Oklo, AppLovin Corp, Viking Therapeutics And Novo Nordisk: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices closed mixed on Tuesday, with the Dow Jones Industrial Average climbing 1.2% to 47,927.96 and the S&P 500 inching up 0.2% to 6,846.61.

Anthropic announces $50B investment in new US data centers to meet AI demand

SAN FRANCISCO (AP) — Artificial intelligence company Anthropic announced a $50 billion investment in computing infrastructure on Wednesday that will include new data centers in Texas and New York.

This Memecoin Looks Like a Joke-But Could Be a Goldmine - Ad

Forget DOGE and SHIB. We've uncovered a hidden memecoin showing surprising signs of strength. Early indicators-community traction, real-world utility, and institutional buzz-suggest this could be the most overlooked crypto play right now.

JPMorgan Raises Forecast On This Warren Buffett Favorite Oil Stock

JP Morgan raises Occidental Petroleum (OXY) price target to $51 after Q3 earnings beat, noting capital reallocation from OxyChem and Low Carbon Ventures to upstream projects.

Watchdog group Public Citizen demands OpenAI withdraw AI video app Sora over deepfake dangers

The tech industry is moving fast and breaking things again — and this time it is humanity’s shared reality and control of our likeness before and after death — thanks to artificial intelligence image-generation platforms .

Trump Just Signed s.1582 Into Law - Now the Countdown Begins... - Ad

A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on November 18. Investors who make the right moves before then could make up to 40X by 2032...

Trump Tells Republicans To Not Be 'Weak:' 'You Will Rue The Day That You Didn't Terminate The…'

Trump urges Republicans to end filibuster and warns of Democratic plans to expand Supreme Court. Government shutdown continues.

Starbucks workers kick off 65-store US strike on company's busy Red Cup Day

More than 1,000 unionized Starbucks workers at 65 U.S. stores Thursday to protest a lack of progress in labor negotiations with the company.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.

Microsoft Builds Massive AI 'Super Factory' In Atlanta To Power OpenAI And Elon Musk's xAI

Microsoft Corp (NASDAQ: MSFT) is building an AI super factory in Atlanta to double its data center footprint and keep up with the $400 billion AI industry.

This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power

Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.

The Real Brains Behind AI Machines - Ad

AI needs more than algorithms. It needs hardware that can think and move - without melting your data center. This one company designs the most efficient chips on the planet, used in billions of devices. And it just helped launch new AI processors for data centers and robotics.

Vietnam's VinFast Hits Over 20,000 Monthly EV Deliveries

VinFast delivered a record 20,380 EVs in Vietnam in October—first local maker to top 20k in a month—even as shares dipped.

Kevin O'Leary Explains Why Marriages Are A Lot Like Business

Marriage is like a business, says O'Leary. Financial partnership is key for long-term success, as money stress is top cause of divorce. Prenups can protect individual wealth.

Forget Amazon's 1997 IPO... This Could Be 287 Times Bigger - Ad

Since Amazon's IPO in 1997, it climbed enough to turn $100 into $250,000. Now, one man says Elon Musk could be gearing up to take his internet satellite giant public... in what Fortune magazine says will be the biggest IPO in history! James Altucher is sharing how ANYONE can get a pre-IPO stake... with as little as $100!

Visa Launches Stablecoin Payouts For The Gig Economy As Traders Eye $343

Visa Inc. (NYSE:V) is shaking up digital payments with a new pilot program that lets creators, freelancers, and gig workers receive instant USDC stablecoin payouts

Nvidia CEO: E.I. Will Be as Common as Cars Today - Ad

E.I. isn't science fiction anymore. It's already here. And one little-known company is quietly supplying the systems behind it. This stock is still under Wall Street's radar... but not for long. You'll get the name, the ticker, and the full thesis inside.

Hyliion Stock Stumbles On Mixed Q3 Earnings Results

Hyliion shares are moving lower in extended trading Tuesday after the company reported mixed financial results for the third quarter.

Best ETF For The Critical Minerals Boom? Here Are Rare Earth Winners

Here's how VanEck's REMX and Amplify's BATT stack up in the fight for dominance over critical minerals and the clean energy supply chain.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Cathie Wood Goes Big On Alibaba With $25 Million Share Purchase, Scales Back On This Social Media Stock

Ark Invest made big moves in its portfolio, focusing on Alibaba, Baidu, and Reddit amid evolving market dynamics and regulatory challenges.

Why Did Salarius (SLRX) Shares Soar Over 23% After-Hours?

Salarius Pharmaceuticals shares jumped 23.7% in after-hours trading Tuesday, closing at $1.21 following its public offering announcement.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

Drone sightings disrupt flights at Belgium's main airport

BRUSSELS (AP) — Flights at Belgium’s main international airport remained disrupted on Wednesday after drone sightings overnight forced it to close temporarily and Prime Minister Bart De Wever called a meeting with senior ministers to discuss safety concerns.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

How Europe's private drone industry eyes opportunity as NATO strengthens defense

AALBORG, Denmark (AP) — In a warehouse more than 1,500 kilometers (900 miles) from Ukraine's capital, workers in northern Denmark painstakingly piece together . Some of the devices will be exported to Kyiv in the hopes of jamming Russian technology on the battlefield, while others will be shipped across Europe in efforts to combat mysterious drone intrusions into NATO's airspace that have the entire continent on edge.

A Low-Profile Memecoin Is Quietly Gaining Serious Momentum - Ad

While everyone's watching the big-name coins, a lesser-known memecoin is gathering speed. With unique utility, a growing user base, and strong chart signals, our research team believes this could be a breakout waiting to happen.

China's car sales slow in October as some trade-in subsidies, tax breaks are phased out

BANGKOK (AP) — China's passenger car sales slowed in October, even for electric vehicle makers BYD and Tesla, as automakers cut prices to compete in an overcrowded market, an industry association said Tuesday.

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.

This Memecoin Looks Like a Joke-But Could Be a Goldmine - Ad

Forget DOGE and SHIB. We've uncovered a hidden memecoin showing surprising signs of strength. Early indicators-community traction, real-world utility, and institutional buzz-suggest this could be the most overlooked crypto play right now.

Traders Love This Time Of Year For Broadcom — Here's Why It Rarely Fails

Broadcom stock has gained in 14 of the last 16 mid-November to mid-December periods, with an average return of 8.9%.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright priceactionea.net
Privacy Policy | Terms of Service